Last updated on March 2019

Lacripep in Subjects With Dry Eye Associated With Primary Sj gren's Syndrome

Brief description of study

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep ophthalmic solution versus placebo administered three times daily for four weeks in subjects with a diagnosis of Dry Eye associated with documented Primary Sjgren's Syndrome

Detailed Study Description

This is a multi-center, randomized, placebo-controlled, double-masked, parallel-group study. Subjects will be randomized into three treatment groups: 0.005%, or 0.01% Lacripep, or placebo in a 1:1:1 ratio.

Clinical Study Identifier: NCT03226444

Contact Investigators or Research Sites near you

Start Over

Abrams Eye Center

Cleveland, OH United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.